GlaxoSmithKline, Pfizer Team Up Against HIV
The collaboration of two pharmaceutical giants may mark the beginning of an industry shift. Pfizer and GlaxoSmithKline are combining their HIV drug businesses into a single, jointly owned company that will account for almost 20 percent of the market.